ADAG · US market
Adagene Inc
Compare this company’s P/E and P/S using trailing results and the latest quarter. Ratios are calculated here from market capitalisation, signed ordinary or common-shareholder earnings and revenue.
Market cap US$138.84mFinancials dated 31 December 2025Price dated 1 October 2026
Core valuation
* P/E uses the latest reported full year ended 31 December 2025 because neither a trailing four-quarter value nor a latest-quarter value is available.
* P/S uses the latest reported full year ended 31 December 2025 because neither a trailing four-quarter value nor a latest-quarter value is available.
Calculation inputs
- Trailing earnings
- Unavailable
- Latest-quarter run-rate earnings
- Unavailable
- Latest fiscal-year earnings
- -US$17.61m
- Trailing revenue
- Unavailable
- Latest-quarter run-rate revenue
- Unavailable
- Latest fiscal-year revenue
- US$7.67m
Featured ETF and mutual-fund exposure
These public funds report this company in their latest disclosed holdings.
- PGJ · Invesco Golden Dragon China ETF0.18% weight · Holdings dated 19 August 2026
- FNCMX · Fidelity NASDAQ Composite Index Fund0.00% weight · Holdings dated 31 May 2026
Sources and limitations
Financial inputs are attributed to SEC EDGAR. Market cap is calculated locally where auditable price and share inputs are available. Missing data stays missing; losses are retained as signed values and produce a numeric signed P/E.
Open financial sourceFinancials as of 31 December 2025. Informational research, not investment advice.